Health Care M&A Weekly Deals, The Week Ending June 8, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report.

This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search.

Biotechnology
AcquirerTargetPrice
Axovant Sciences Ltd.Exclusive worldwide license to OXB-102$30 million
Gilead Sciences, Inc.Exclusive license to 2 immunization technologies$10 million
Yakult Honsha Co., Ltd.Exclusive license to duvelisib in Japan$10 million
CStone PharmaceuticalsExclusive license to avapritinib, BLU-554 & BLU-667$40 million
Versartis, Inc.Aravive Biologics, Inc.Merger
ACON Investments and Humus Capital PartnersBiosidus S.A. and Biosidus Farma S.A.N/A
eHealth
AcquirerTargetPrice
Teladoc, Inc.Advance Medical$352 million
Medical Devices
AcquirerTargetPrice
CoreLink, LLCExpanding Orthopedics, IncN/A
Physician Medical Groups
AcquirerTargetPrice
Strategic Health Services, LLCJay Care Medical Center, Inc.N/A
New Enterprise Associates, Inc.Paladina Health$100 million
CranemereNorthStar AnesthesiaN/A
Gryphon InvestorsWater’s Edge DermatologyN/A
Inception Fertility VenturesRMA of TexasN/A
Other
AcquirerTargetPrice
Mitchell International, Inc.Medical Consultants NetworkN/A
CORDENTAL GroupDrs. Melman, Ravett & AssociatesN/A
CRYO-CELL International, Inc.Cord:Use Cord Blood Bank Inc.$14 million
   

 

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *